![](https://cust-images.grenadine.co/imgproxy/fill/256/256/sm/1/aHR0cHM6Ly9zMy5hbWF6b25hd3MuY29tL3B1YmxpYy5ncmVuYWRpbmUuY28vZ2xvYmFsLzM4Ny8zNDcvYmQxODJkNjUzODFhYmE5NjU0M2RlMmJhNzJmY2RjMzkuanBn.jpg)
Mélanie Hébert is an ophthalmology resident at Université Laval, Québec, Canada. At Université de Montréal, she obtained her medical degree and master’s degree in biomedical sciences concurrently for which she was awarded the FRQS Master’s Training for Medical Students and CIHR Canada Graduate Scholarships. She was also the recipient of several ophthalmology research awards, including the Clinician Scientist Emerging Leader Award from Fighting Blindness Canada. Her research interests span every ophthalmology subspecialty, particularly immediately sequential bilateral cataract surgery (ISBCS), surgical outcomes in vitreoretinal surgery, and uveitis.
Sessions auxquelles Mélanie Hébert participe
Vendredi 10 Juin, 2022
Samedi 11 Juin, 2022
Sessions auxquelles Mélanie Hébert assiste
Jeudi 9 Juin, 2022
Vendredi 10 Juin, 2022
Samedi 11 Juin, 2022
Objectifs d’apprentissageÀ la fin de la session, les participants pourront :Repérer des propositions canadiennes novatrices de recherche en rétine et les avantages escomptésDécrire comment l’utilisation des innovations numériques en ophtalmologie peut optimiser les soins aux patientsRôles CanMEDS : Érudit, expert médicale Le présent symposium a été élaboré conjointement avec la SCO et Bayer de man...
Dimanche 12 Juin, 2022
LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...